» Articles » PMID: 3924954

Familial Gynecomastia with Increased Extraglandular Aromatization of Plasma Carbon19-steroids

Overview
Journal J Clin Invest
Specialty General Medicine
Date 1985 Jun 1
PMID 3924954
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

We evaluated a family in which gynecomastia occurred in five males in two generations. In each affected subject, gynecomastia and male sexual maturation began at an early age. The ratio of the concentration of plasma estradiol-17 beta to that of plasma testosterone was elevated in each affected subject. In the three siblings with gynecomastia, the transfer constant of conversion of androstenedione to estrone (i.e., the fraction of plasma androstenedione that was converted to estrone as measured in the urine) was 10 times that of normal persons. The transfer constant of conversion of testosterone to estradiol-17 beta in the one subject studied also was 8-10 times that of normal men, whereas the transfer constants of conversion of estrone to estradiol-17 beta and of estradiol-17 beta to estrone were normal. Despite the elevation in extraglandular aromatase activity, there was a normal response of the hypothalamic-pituitary axis to provocative stimuli. This is the second documentation of gynecomastia that is associated with increased extraglandular aromatase activity, and the first time that the defect was found to be familial with a probable X-linked (or autosomal dominant, sex limited) mode of inheritance.

Citing Articles

The effect of androstenedione supplementation on testosterone, estradiol, body composition, and lipid profile: a systematic review and meta-analysis of randomized controlled trials.

Pang Q, Jia A, Al Masri M, Kord Varkaneh H, Abu-Zaid A, Gao X Hormones (Athens). 2022; 21(4):545-554.

PMID: 35841524 DOI: 10.1007/s42000-022-00385-8.


Prepubertal unilateral gynecomastia in the absence of endocrine abnormalities.

Kang M, Lee C, Hwang I, Lee K, Kang M Ann Pediatr Endocrinol Metab. 2014; 19(3):159-63.

PMID: 25346921 PMC: 4208259. DOI: 10.6065/apem.2014.19.3.159.


Understanding the pathological manifestations of aromatase excess syndrome: lessons for clinical diagnosis.

Shozu M, Fukami M, Ogata T Expert Rev Endocrinol Metab. 2014; 9(4):397-409.

PMID: 25264451 PMC: 4162655. DOI: 10.1586/17446651.2014.926810.


Aromatase excess syndrome presenting with prepubertal gynecomastia in an Egyptian child with type 1 neurofibromatosis.

Metwalley K, Farghaly H Indian J Hum Genet. 2014; 19(4):472-4.

PMID: 24497716 PMC: 3897146. DOI: 10.4103/0971-6866.124379.


An aroma of complexity: how the unique genetics of aromatase (CYP19A1) explain diverse phenotypes from hens and hyenas to human gynecomastia, and testicular and other tumors.

Stratakis C J Clin Endocrinol Metab. 2013; 98(12):4676-81.

PMID: 24311795 PMC: 3849672. DOI: 10.1210/jc.2013-3990.


References
1.
Odell W, ROSS G, Rayford P . Radioimmunoassay for human luteinizing hormone. Metabolism. 1966; 15(4):287-9. DOI: 10.1016/0026-0495(66)90142-9. View

2.
Longcope C, Sato K, Mckay C, Horton R . Aromatization by splanchnic tissue in men. J Clin Endocrinol Metab. 1984; 58(6):1089-93. DOI: 10.1210/jcem-58-6-1089. View

3.
Foley Jr T, Jacobs L, Hoffman W, Daughaday W, BLIZZARD R . Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone. J Clin Invest. 1972; 51(8):2143-50. PMC: 292371. DOI: 10.1172/JCI107021. View

4.
Weinstein R, Kelch R, Jenner M, Kaplan S, Grumbach M . Secretion of unconjugated androgens and estrogens by the normal and abnormal human testis before and after human chorionic gonadotropin. J Clin Invest. 1974; 53(1):1-6. PMC: 301431. DOI: 10.1172/JCI107526. View

5.
Judd H, Parker D, Siler T, Yen S . The nocturnal rise of plasma testosterone in pubertal boys. J Clin Endocrinol Metab. 1974; 38(4):710-3. DOI: 10.1210/jcem-38-4-710. View